These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9104896)

  • 1. Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators.
    Eisenberg MJ; Califf RM; Cohen EA; Adelman AG; Mark DB; Topol EJ
    Am J Cardiol; 1997 Apr; 79(7):867-72. PubMed ID: 9104896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial.
    Levine GN; Jacobs AK; Keeler GP; Whitlow PL; Berdan LG; Leya F; Topol EJ; Califf RM
    Am J Cardiol; 1997 Mar; 79(6):748-55. PubMed ID: 9070553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
    Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
    Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II Investigators.
    Omoigui NA; Silver MJ; Rybicki LA; Rosenthal M; Berdan LG; Pieper K; King SV; Califf RM; Topol EJ
    J Am Coll Cardiol; 1998 Feb; 31(2):265-72. PubMed ID: 9462565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I).
    Elliott JM; Berdan LG; Holmes DR; Isner JM; King SB; Keeler GP; Kearney M; Califf RM; Topol EJ
    Circulation; 1995 Apr; 91(8):2158-66. PubMed ID: 7697844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of secondary prevention in patients undergoing coronary revascularization.
    Allen JK; Blumenthal RS; Margolis S; Young DR
    Am J Cardiol; 2001 May; 87(10):1203-6: A7. PubMed ID: 11356400
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I).
    Omoigui NA; Califf RM; Pieper K; Keeler G; O'Hanesian MA; Berdan LG; Mark DB; Talley JD; Topol EJ
    J Am Coll Cardiol; 1995 Oct; 26(4):922-30. PubMed ID: 7560619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of calcium channel antagonists in myocardial revascularization procedures.
    Califf RM; Tardiff BE; Pieper KS; Hillegass WB
    Am J Cardiol; 1996 Jun; 77(16):26D-31D. PubMed ID: 8677894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug prescription in the post-percutaneous coronary interventions period: results of the ECART study].
    Philippe F; Sebaoun A; Avierinos C; Julien G
    Ann Cardiol Angeiol (Paris); 2004 Jun; 53(3):131-6. PubMed ID: 15291168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.
    Sharma KK; Gupta R; Agrawal A; Roy S; Kasliwal A; Bana A; Tongia RK; Deedwania PC
    Vasc Health Risk Manag; 2009; 5():1007-14. PubMed ID: 19997570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical therapy after successful percutaneous coronary revascularization.
    Hasdai D; Lerman A; Grill DE; Rihal CS; Holmes DR
    Ann Intern Med; 1999 Jan; 130(2):108-15. PubMed ID: 10068356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of stenotic lesion morphology on immediate and long-term (6 months) angiographic outcome: comparative analysis of directional coronary atherectomy versus standard balloon angioplasty.
    Kimball BP; Cohen EA; Adelman AG
    J Am Coll Cardiol; 1996 Mar; 27(3):543-51. PubMed ID: 8606263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial.
    Alexander KP; Peterson ED; Granger CB; Casas AC; Van de Werf F; Armstrong PW; Guerci A; Topol EJ; Califf RM
    J Am Coll Cardiol; 1998 Dec; 32(7):2023-30. PubMed ID: 9857888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrupt closure: the CAVEAT I experience. Coronary Angioplasty Versus Excisional Atherectomy Trial.
    Holmes DR; Simpson JB; Berdan LG; Gottlieb RS; Leya F; Keeler GP; Califf RM; Topol EJ
    J Am Coll Cardiol; 1995 Nov; 26(6):1494-500. PubMed ID: 7594076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).
    Langer A; Fisher M; Califf RM; Goodman S; O'Connor CM; Harrington RA; Fuster V
    Can J Cardiol; 1999 Oct; 15(10):1095-102. PubMed ID: 10523476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends in patient-reported angina at 1 year after percutaneous coronary revascularization in the stent era: a report from the National Heart, Lung, and Blood Institute-sponsored 1997-2006 dynamic registry.
    Venkitachalam L; Kip KE; Mulukutla SR; Selzer F; Laskey W; Slater J; Cohen HA; Wilensky RL; Williams DO; Marroquin OC; Sutton-Tyrrell K; Bunker CH; Kelsey SF;
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):607-15. PubMed ID: 20031899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
    Deedwania PC; Carbajal EV
    Am J Med; 2011 Aug; 124(8):681-8. PubMed ID: 21787900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
    Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
    JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.